Argan Oil Exerts an Antiatherogenic Effect by Improving Lipids and Susceptibility of LDL to Oxidation in Type 2 Diabetes Patients

Table 3

Variations of different parameters in both groups after three weeks of intervention.

Groups		Parameters
		TC (mg/dL)	TG (mg/dL)	LDL-chol (mg/dL)	HDL-chol (mg/dL)	Apo AI (mg/dL)	Apo B (mg/dL)	ApoB/Apo AI	CRP (mg/dL)	CRE (mg/dL)
Control	After stabilization (2 weeks)	191±37	150±56	127±33	34±5	106.24±14	86.83±20.63	0.66±0.10	3.96±1.4	6.07±1.2
	After intervention (3 weeks)	192±35	148±54	127±34	35±5	105.71±17	88.11±13.02	0.67±0.17	4.0±1.5	6.21±1.4
	𝑃	0.331	0.367	0.451	0.329	0.358	0.462	0.405	0.427	0.391
Argan oil	After stabilization (2 weeks)	197±35	152±55	127±39	39±7	106.84±17	82.90±20.13	0.65±0.13	4.27±1.7	4.65±1.16
	After intervention (3 weeks)	179±36	134±43	112±33	43±10	117.52±10	79.00±14.08	0.63±0.12	4.02±1.34	4.63±1.36
	𝑃	0.012	0.001	0.024	0.013	0.017	0.147	0.092	0.075	0.316

Abbreviations: Apo AI: apolipoprotein AI; Apo B: apolipoprotein B; CRE: creatinine; CRP: C-reactive protein; HDL-chol: high density lipoprotein cholesterol; LDL-chol: low density lipoprotein cholesterol; TC: total cholesterol; TG: triglycerides. Values are mean ± SD.